Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use

Andrew J. Neal; Bruce C V Campbell; Arvind Chandratheva; Peter J. Hand; Stephen M. Davis

doi:10.1016/j.jocn.2014.03.029

Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use

Andrew J. Neal
, Bruce C V Campbell
, Arvind Chandratheva
, Peter J. Hand
, Stephen M. Davis

Research output: Contribution to journal › Article › Other › peer-review

10 Citations (Scopus)

Abstract

The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.

Original language	English
Pages (from-to)	2013-2015
Number of pages	3
Journal	Journal of Clinical Neuroscience
Volume	21
Issue number	11
DOIs	https://doi.org/10.1016/j.jocn.2014.03.029
Publication status	Published - 1 Nov 2014
Externally published	Yes

Keywords

Rivaroxaban
Stroke
Thrombolysis
Thrombolytic therapy

Access to Document

10.1016/j.jocn.2014.03.029

Cite this

@article{1ffaf3c988fd45bda12abc5428b4d0e5,

title = "Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use",

abstract = "The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.",

keywords = "Rivaroxaban, Stroke, Thrombolysis, Thrombolytic therapy",

author = "Neal, \{Andrew J.\} and Campbell, \{Bruce C V\} and Arvind Chandratheva and Hand, \{Peter J.\} and Davis, \{Stephen M.\}",

year = "2014",

month = nov,

day = "1",

doi = "10.1016/j.jocn.2014.03.029",

language = "English",

volume = "21",

pages = "2013--2015",

journal = "Journal of Clinical Neuroscience",

issn = "0967-5868",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use

AU - Neal, Andrew J.

AU - Campbell, Bruce C V

AU - Chandratheva, Arvind

AU - Hand, Peter J.

AU - Davis, Stephen M.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.

AB - The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.

KW - Rivaroxaban

KW - Stroke

KW - Thrombolysis

KW - Thrombolytic therapy

UR - https://www.scopus.com/pages/publications/84908380520

U2 - 10.1016/j.jocn.2014.03.029

DO - 10.1016/j.jocn.2014.03.029

M3 - Article

C2 - 24984844

SN - 0967-5868

VL - 21

SP - 2013

EP - 2015

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

IS - 11

ER -

Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use

Abstract

Keywords

Access to Document

Other files and links

Cite this